Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07ZUZ
|
|||
Former ID |
DIB006431
|
|||
Drug Name |
CK-2127107
|
|||
Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 2 | [1] | |
Spinal muscular atrophy [ICD-11: 8B61] | Phase 2 | [1] | ||
Muscle atrophy [ICD-11: FB32.Y; ICD-9: 728.2] | Phase 1 | [2] | ||
Company |
Cytokinetics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H18F2N6O
|
|||
Canonical SMILES |
C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F
|
|||
InChI |
1S/C19H18F2N6O/c20-13-6-19(7-13,16-15(21)2-1-4-23-16)11-26-18-24-8-14(9-25-18)27-5-3-12(10-27)17(22)28/h1-5,8-10,13H,6-7,11H2,(H2,22,28)(H,24,25,26)
|
|||
InChIKey |
MQXWPWOCXGARRK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1345410-31-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fast skeletal muscle troponin complex (TNNC2) | Target Info | Modulator | [3] |
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Striated Muscle Contraction | |||
WikiPathways | Striated Muscle Contraction | |||
Muscle contraction |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037810) | |||
REF 3 | Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases. Nat Med. 2012 Feb 19;18(3):452-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.